Future Proof CEO Matt Middleton organizes annual industry events that use technology to encourage networking and engagement among financial advisors, with over half of attendees being first-timers. The festival avoids traditional paid speaking slots, instead focusing on shared experiences and group activities to build professional relationships. Middleton invested heavily in this model, leading to the expansion of Future Proof into executive retreats and citywide editions. Upcoming events will address the integration of artificial intelligence into wealth management, with Middleton forecasting that advisor businesses will adopt AI-driven operations within three to five years. The events aim to enhance, not replace, human connections through technology.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

The Construction Owners Summit Atlanta 2025 will take place on September 22 at Kennesaw State University, organized by Lumber and the Construction Owner Club. The event will focus on careers in construction, mental health, and artificial intelligence, featuring sessions on AI-driven recruitment, workforce engagement, technology adoption strategies, and compliance improvements through autonomous AI systems. Industry leaders, students, and technology experts will participate, with additional summits planned in Santa Clara, Phoenix, and Chicago to address industry challenges and promote innovation.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

Condor Technology, through its subsidiary Condor Computing, introduced the Cuzco RISC-V CPU for datacenter applications. The Cuzco core supports up to eight cores with private L2 and shared L3 cache, features a 12-stage pipeline, and uses a time-based instruction scheduling system to reduce power consumption. Andes Technology, a founding member of RISC-V International, reported $42 million in 2024 sales and shipped IP for over 17 billion RISC-V chips since 2005. Nearly 40 percent of Andes' 2024 revenue came from AI sector deployments. Major technology companies and the European Union are investing in RISC-V, with the first Cuzco processors expected to reach users by year-end.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

Leaders from defense, aviation, and space sectors met at the Global Aerospace Summit to address evolving threats, focusing on advanced technologies and workforce development. Industry and government representatives highlighted the integration of artificial intelligence in defense systems and aviation operations, with companies like United Airlines and defense contractors deploying AI to improve efficiency and decision-making. Policymakers emphasized the need for consistent investment, secure supply chains for critical minerals, and federal funding to maintain U.S. leadership. Initiatives in education and vocational training are expanding the aerospace talent pipeline, with state leaders streamlining regulations and leveraging higher education to attract industry growth.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

Utah invested $100 million in the Responsible AI Initiative at the University of Utah to attract researchers, expand cyberinfrastructure, and create a safe environment for AI development. The state enacted the first U.S. AI law requiring business accountability for AI misconduct and disclosure of generative AI use in regulated professions. Utah established the Office of Artificial Intelligence Policy and the Artificial Intelligence Learning Laboratory Program. Officials plan to address companion AI and deepfakes in future legislation and are partnering with companies like NVIDIA to integrate AI training into education and workforce development.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

Innodata expands partnerships with major technology companies, reporting $33.9 million in quarterly revenue from its largest customer and projecting $10 million from a new client in the second half of 2025. The company develops a late-stage pipeline of additional technology firm engagements and aims to shift from project-based work to long-term collaborations in artificial intelligence. Microsoft and Palantir Technologies also expand their AI service offerings, increasing competition in the sector.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

Debojyoti Dutta, Chief AI Officer at Nutanix, states that successful enterprise AI integration relies on balancing people, process, and technology. He reports that companies must retrain teams, update workflows, and ensure clean, well-governed data to achieve effective AI adoption. Dutta emphasizes that widespread use of AI tools across departments is necessary for operational improvements and that ongoing human oversight remains important as AI agents become more common. He notes that Nutanix has observed system reliability gains from this approach and projects further advancements with digital assistants, provided organizations maintain strong foundational practices.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.

MIT researchers developed a device for targeted bladder cancer drug delivery, leading to the creation of TARIS Biomedical, which was later acquired by Johnson & Johnson. The device, designed to integrate with existing urological procedures, delivers medication directly to the bladder over two weeks and is removed with a standard cystoscope. Clinical trials showed that over 80 percent of high-risk, non-muscle-invasive bladder cancer patients had no evidence of disease after treatment, with more than half remaining cancer-free at nine months. The system received FDA approval and is being considered for use in other diseases.

Learn more on this news by visiting us at: https://greyjournal.net/news/

Hosted on Acast. See acast.com/privacy for more information.